Doctor Holding WATCHMAN device

WATCHMAN FLXTM
The One-Time Procedure

That may provide a long-term stroke risk reduction in NVAF patients

See which patients are right for WATCHMAN FLX
WATCHMAN Device

Think Outside the Pillbox

WATCHMAN is the most studied and implanted LAA Closure device in the world with 15 years/6,000 patient years studied and WATCHMAN FLX, the new generation LAAC device, is designed to advance procedural performance and safety while expanding the treatable patient population.

Innovative
One-Time Solution

Review the clinical data that reinforces why LAAC is a proven stroke risk reduction option
 

analytics visual

The Implant
Procedure

Learn about the WATCHMAN FLX LAAC Implant procedure and how it can help you manage stroke risk for your patients with non-valvular atrial fibrillation (NVAF)

WATCHMAN device implanted

Who is
LAA Closure for?

See which of your NVAF patients could benefit from LAA Closure

WATCHMAN patient

Receive WATCHMAN FLX Updates


Sign Up Now

CAUTION:
The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings and instructions for use can be found in the product labelling supplied with each device.
Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries.
This material not intended for use in France.